Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Discovery of a new mechanism of gene control that is associated with cancer

20.06.2011
Scientists at Memorial Sloan-Kettering Cancer Center in New York and at IRB Barcelona reveal the mechanism of action of a protein that is essential for life and is associated with disease.

Researchers headed by Joan Massagué at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York and by María Macías at the Institute for Research in Biomedicine (IRB Barcelona) have identified a complex mechanism by which some proteins that are essential for life, called Smads, regulate the activity of genes associated with cancer.

The fruit of three years of intense work, the study reports on the life cycle of this protein, a process that ensures that the protein is destroyed when it has completed its function. These results have been published today in the top journal Genes & Development, which has devoted its cover to this research.

In the TGF-beta/Smad signal cascade, the hormones TGF-beta and BMP transmit information to the Smad protein in the cell nucleus in order for this molecule to stop cell division and to ensure that tissues grow in an orderly and coordinated manner. Although the TGF-beta/Smad signalling pathway has been known for over twenty years, until now it was unclear how Smads temporally controlled the activity of such important genes. “We had several pieces of the puzzle but we couldn’t put them together”, says Macías.

A number of earlier studies performed by Massagué’s lab had identified that Smads undergo phosphorylations –a kind of chemical change – in a region of the protein about which little is known. By means of biophysical and biochemical approaches, the researchers have discovered that these modifications occur in a coordinated fashion over time and are not random. “First, phosphorylations make some proteins bind to Smads in order to control the activity of target genes and later other phoshorylations cause protein bindings that lead to the destruction of Smad once this protein has completed its mission. This is the way cells prevent fatal errors”, explains Macías.

Having established the time sequence of these events, the scientists used cell and structural biology approaches –determination of the atom position in Smad proteins and other activating and destructor proteins bound to them– to confirm the results previously found. “We have been able to decipher the specificity of the binding between Smad and other proteins and to reveal the secret code that these proteins use to extract information”.

How do these proteins favour tumour cells? Massagué explains that “these signalling cascades are like the body’s pólice force. The tumour cells, in other words the delinquents, disturb these pathways and use them for their own means to grow and spread”. These pathways normally are involved in basic cell processes but when altered by mutations several diseases can appear such as cancer, congenital conditions, chronic inflammation and emphysema. These results could serve as the foundation on which to develop new clinical treatments against cancer and other diseases.

Reference article:
A Smad action-turnover switch operated by WW domain readers of a phosphoserine code. Eric Aragón, Nina Goerner, Alexia-Ileana Zaromytidou, Qiaoran Xi, Albert Escobedo, Joan Massagué, and Maria J. Macias.

Genes & Development (2011). [doi: 10.1101/gad.2060811]

Nuria Noriega | EurekAlert!
Further information:
http://www.irbbarcelona.org

More articles from Life Sciences:

nachricht Molecular Force Sensors
20.09.2017 | Max-Planck-Institut für Biochemie

nachricht Foster tadpoles trigger parental instinct in poison frogs
20.09.2017 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Molecular Force Sensors

20.09.2017 | Life Sciences

Producing electricity during flight

20.09.2017 | Power and Electrical Engineering

Tiny lasers from a gallery of whispers

20.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>